中药注射剂因其起效快,作用迅速,而且在很大程度上保留了传统中药辨证施治的特点,受到了医生和患者的青睐。但是,越来越多的中药注射剂不良反应的报道却大大限制了其应用。一直以来,药品安全问题无论在中外都受到密切关注。从上世纪60年代震惊世界的“反应停”事件,到2004年默克公司将已经上市5年的镇痛药罗非昔布(万络,长期使用会增加心脏病发作和中风的危险)主动撤市,药品安全问题日益受到重视。药物警戒作为一门新兴的学科对此起到了巨大作用。因此,应用药 Traditional Chinese medicine injections because of its rapid onset, rapid effect, and to a large extent retained the characteristics of traditional Chinese medicine syndrome differentiation, by the doctors and patients of all ages. However, the reports of more and more traditional Chinese medicine injection adverse reactions have greatly limited its application. All along, the issue of drug safety has been closely watched both at home and abroad. From the “reaction stoppage” that shocked the world in the 1960s to 2004, Merck will have already listed the analgesic rofecoxib, which has been on the market for five years, in 2004 (Wanluo, long-term use will increase the risk of heart attack and stroke ) Take the initiative to withdraw the market, drug safety issues are increasingly valued. Pharmacovigilance has played a huge role as a new discipline. Therefore, the application of medicine